3//SEC Filing
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC 3
Accession 0001628280-21-020187
CIK 0001819113operating
Filed
Oct 17, 8:00 PM ET
Accepted
Oct 18, 4:46 PM ET
Size
14.2 KB
Accession
0001628280-21-020187
Insider Transaction Report
Form 3
Eagle Holding Co II, LLC
10% Owner
Holdings
- 17,314,315
Common Stock
Holdings
- 17,314,315
Common Stock
Jaguar Holding Co I, LLC
10% Owner
Holdings
- 17,314,315
Common Stock
Jaguar Holding Co II
10% Owner
Holdings
- 17,314,315
Common Stock
PPD, Inc.
10% Owner
Holdings
- 17,314,315
Common Stock
Holdings
- 17,314,315
Common Stock
Footnotes (2)
- [F1]These shares of common stock, par value $0.0001 per share, of Science 37 Holdings, Inc. are held of record by Pharmaceutical Product Development, LLC ("Pharma LLC"). Wildcat Acquisition Holdings (UK) Limited ("Wildcat") is the sole member of Pharma LLC; Jaguar Holding Company II ("Jaguar II") is the sole shareholder of Wildcat; Jaguar Holding Company I, LLC ("Jaguar I") is the sole shareholder of Jaguar II; Eagle Holding Company II, LLC ("Eagle II") is the sole member of Jaguar I; and PPD, Inc. is the sole member of Eagle II. By virtue of such relationships, each of the reporting persons may be deemed to have beneficial ownership over such shares of common stock.
- [F2]This report on Form 3 is jointly filed by the reporting persons. Each of the reporting persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein.
Documents
Issuer
Science 37 Holdings, Inc.
CIK 0001819113
Entity typeoperating
IncorporatedNC
Related Parties
1- filerCIK 0001003124
Filing Metadata
- Form type
- 3
- Filed
- Oct 17, 8:00 PM ET
- Accepted
- Oct 18, 4:46 PM ET
- Size
- 14.2 KB